Lataa...
Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock
Sacubitril/valsartan is a combination drug described as a new class of dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for heart failure. We present a case of a patient with NYHA class IV systolic heart failure who was refractory to all other classes of heart failure medications and was...
Tallennettuna:
| Julkaisussa: | Case Rep Cardiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976952/ https://ncbi.nlm.nih.gov/pubmed/29862089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8231576 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|